197 related articles for article (PubMed ID: 24706857)
21. Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram Syndrome 2.
Conlan AR; Axelrod HL; Cohen AE; Abresch EC; Zuris J; Yee D; Nechushtai R; Jennings PA; Paddock ML
J Mol Biol; 2009 Sep; 392(1):143-53. PubMed ID: 19580816
[TBL] [Abstract][Full Text] [Related]
22. Binding of Nitric Oxide in CDGSH-type [2Fe-2S] Clusters of the Human Mitochondrial Protein Miner2.
Cheng Z; Landry AP; Wang Y; Ding H
J Biol Chem; 2017 Feb; 292(8):3146-3153. PubMed ID: 28082676
[TBL] [Abstract][Full Text] [Related]
23. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.
Rong YP; Bultynck G; Aromolaran AS; Zhong F; Parys JB; De Smedt H; Mignery GA; Roderick HL; Bootman MD; Distelhorst CW
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14397-402. PubMed ID: 19706527
[TBL] [Abstract][Full Text] [Related]
24. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum.
Lian J; Wu X; He F; Karnak D; Tang W; Meng Y; Xiang D; Ji M; Lawrence TS; Xu L
Cell Death Differ; 2011 Jan; 18(1):60-71. PubMed ID: 20577262
[TBL] [Abstract][Full Text] [Related]
25. After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilization.
Ding J; Mooers BHM; Zhang Z; Kale J; Falcone D; McNichol J; Huang B; Zhang XC; Xing C; Andrews DW; Lin J
J Biol Chem; 2014 Apr; 289(17):11873-11896. PubMed ID: 24616095
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism.
Barclay LA; Wales TE; Garner TP; Wachter F; Lee S; Guerra RM; Stewart ML; Braun CR; Bird GH; Gavathiotis E; Engen JR; Walensky LD
Mol Cell; 2015 Mar; 57(5):873-886. PubMed ID: 25684204
[TBL] [Abstract][Full Text] [Related]
27. The novel small molecular BH3 mimetics SM3 and its regulation of cell apoptosis and autophagy.
Wang Y; Fan S; Li X; Xiaokaiti Y; Pan Y; Tie L; Li X
Biochem Biophys Res Commun; 2019 Sep; 517(1):15-22. PubMed ID: 31303271
[TBL] [Abstract][Full Text] [Related]
28. NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer.
Mittler R; Darash-Yahana M; Sohn YS; Bai F; Song L; Cabantchik IZ; Jennings PA; Onuchic JN; Nechushtai R
Antioxid Redox Signal; 2019 Mar; 30(8):1083-1095. PubMed ID: 29463105
[TBL] [Abstract][Full Text] [Related]
29. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
30. Involvement of both mitochondrial- and death receptor-dependent apoptotic pathways regulated by Bcl-2 family in sodium fluoride-induced apoptosis of the human gingival fibroblasts.
Lee JH; Jung JY; Jeong YJ; Park JH; Yang KH; Choi NK; Kim SH; Kim WJ
Toxicology; 2008 Jan; 243(3):340-7. PubMed ID: 18069112
[TBL] [Abstract][Full Text] [Related]
31. NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.
Sohn YS; Tamir S; Song L; Michaeli D; Matouk I; Conlan AR; Harir Y; Holt SH; Shulaev V; Paddock ML; Hochberg A; Cabanchick IZ; Onuchic JN; Jennings PA; Nechushtai R; Mittler R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14676-81. PubMed ID: 23959881
[TBL] [Abstract][Full Text] [Related]
32. Targeting Bcl-2-IP
Distelhorst CW
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1795-1804. PubMed ID: 30053503
[TBL] [Abstract][Full Text] [Related]
33. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Shin JS; Ha JH; Chi SW
Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
[TBL] [Abstract][Full Text] [Related]
34. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
35. In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2.
London N; Gullá S; Keating AE; Schueler-Furman O
Biochemistry; 2012 Jul; 51(29):5841-50. PubMed ID: 22702834
[TBL] [Abstract][Full Text] [Related]
36. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides.
Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE
Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773
[TBL] [Abstract][Full Text] [Related]
37. Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Lee DH; Ha JH; Kim Y; Bae KH; Park JY; Choi WS; Yoon HS; Park SG; Park BC; Yi GS; Chi SW
Biochem Biophys Res Commun; 2011 May; 408(4):541-7. PubMed ID: 21527247
[TBL] [Abstract][Full Text] [Related]
38. Orphan Nuclear Receptor NR4A1 Binds a Novel Protein Interaction Site on Anti-apoptotic B Cell Lymphoma Gene 2 Family Proteins.
Godoi PHC; Wilkie-Grantham RP; Hishiki A; Sano R; Matsuzawa Y; Yanagi H; Munte CE; Chen Y; Yao Y; Marassi FM; Kalbitzer HR; Matsuzawa SI; Reed JC
J Biol Chem; 2016 Jul; 291(27):14072-14084. PubMed ID: 27129202
[TBL] [Abstract][Full Text] [Related]
39. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells.
Lian J; Karnak D; Xu L
Autophagy; 2010 Nov; 6(8):1201-3. PubMed ID: 20930561
[TBL] [Abstract][Full Text] [Related]
40. Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.
Trisciuoglio D; De Luca T; Desideri M; Passeri D; Gabellini C; Scarpino S; Liang C; Orlandi A; Del Bufalo D
Neoplasia; 2013 Mar; 15(3):315-27. PubMed ID: 23479509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
